柳氮磺吡啶 T0907

Product Introduction
Bioactivity


英文名: Sulfasalazine

描述: Sulfasalazine (Azulfidine) 是一种合成的水杨酸衍生物，对含有弹性蛋白的结缔组织具有亲和力，并配制成前药。

细胞实验: Sulfasalazine is dissolved in culture medium. SW620 cells are grown in Dulbecco's modified Eagle medium, supplemented with 10% heat-inactivated FCS, 2 mmol/liter glutamine, and 1% (wt/vol) penicillin/streptomycin. SW620 cells are transfected with the 3xIgkBLuc reporter construct. After 18 h, cells are incubated with either medium alone or with sulfasalazine (0.1, 0.2, 0.5, 1, 2, 5 mM) before stimulation with TNFα, LPS, or PMA. Luciferase assay is performed[1].

体外活性: Sulfasalazine, like methotrexate, enhances adenosine release at an inflamed site and that adenosine diminishes inflammation via occupancy of A2 receptors on inflammatory cells. [1] Sulfasalazine treatment for 4 hours inhibits kappaB-dependent transcription with an IC50 value of approximately 0.625 mM. Sulfasalazine (2.5 mM) results in cell death of T-lymphocytes in a dose- and time-dependent manner. Sulfasalazine but not 5ASA or sulfapyridine, strongly inhibits NF-kappaB activation and potently induces apoptosis in T-lymphocytes. [2] Sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid (5-ASA; mesalamine) by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity. Sulfasalazine but not its cleaved form 5-ASA causes a dose-dependent inhibition of glioma growth, this effect is entirely attributable to the inhibition of cystine uptake via the system x(c)(-) cystine-glutamate transporter. Sulfasalazine inhibits cystine uptake causing a chronic depletion of intracellular GSH and consequently compromised cellular redox defense which stymied tumor growth. [3]

体内活性: Sulfasalazine markedly decreases the number of leukocytes that accumulated in the inflamed (carrageenan, 2 mg/ml) air pouch in the murine air pouch model of inflammation. Sulfasalazine treatment promotes a marked increase in splenocyte 5-aminoimidazole-4-carboxamidoribonucleotide (AICAR) concentration, which is consistent with the in vitro observation that sulfasalazine inhibits AICAR transformylase. [1]

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 60 mg/mL (150.61 mM)


关键字: Nuclear factor-κB | NF-κB | Apoptosis | Autophagy | Ferroptosis | Inhibitor | Nuclear factor-kappaB | Bacterial | Sulfasalazine | inhibit | Antibiotic | NSC667219 | NSC-667219

相关产品: Fenoprofen calcium hydrate | AZD5582 TFA | TBHQ | Concanavalin A | Wedelolactone | (E)-Methyl 4-coumarate | Rosmarinic acid | Sal003 | dBET6 | Illudin S

相关库: Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | Oxidation-Reduction Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Human Metabolite Library | CNS-Penetrant Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Stem Cell Differentiation Compound Library

柳氮磺吡啶 T0907信息由TargetMol中国为您提供，如您想了解更多关于柳氮磺吡啶 T0907报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途